Novo Nordisk A/S (NYSE:NVO)

55.18
Delayed Data
As of Jul 02
 -0.26 / -0.47%
Today’s Change
41.72
Today|||52-Week Range
58.21
+30.39%
Year-to-Date

Stock Price Forecast

The 34 analysts offering 12-month price forecasts for Novo Nordisk have a median target of 61.74, with a high estimate of 76.37 and a low estimate of 40.24. The median estimate represents a +11.89% increase from the last price of 55.18.

Analyst Recommendations

The current consensus among 35 polled investment analysts is to Buy stock in Novo Nordisk. This rating has held steady since June, when it was unchanged from a Buy rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
$0.47
Sales
$4.1B
Reporting Date
Aug 06

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly -17.71%
 
 
 
 
 
 
Growthannually 16.99%
 
 
 
 
 
 

Sales

Growthquarterly 7.32%
 
 
 
 
 
 
Growthannually 12.13%
 
 
 
 
 
 
Key to the earnings and sales forecast charts.

To view my watchlist

Not a member yet?

Sign up now for a free account